(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
...
...
...
Veeral Desai, Chief Strategy & Development Officer, on April 21, 2022, sold 106,357 shares in Agilon Health (AGL) for $2,169,952. Following the Form 4...
Veeral Desai, Chief Strategy & Development Officer, on April 19, 2022, sold 212,714 shares in Agilon Health (AGL) for $4,794,574. Following the Form 4...
Benjamin Kornitzer, Chief Medical & Quality Officer, on April 18, 2022, sold 12,773 shares in Agilon Health (AGL) for $286,033. Following the Form 4 filing...
agilon health (AGL) has an average rating of buy and price targets ranging from $25 to $41, according to analysts polled by Capital IQ. (MT Newswires...
Agilon health (AGL) has an average rating of buy and price targets ranging from $25 to $41, according to analysts polled by Capital IQ. (MT Newswires...
Veeral Desai, Chief Strategy and Development Officer, on March 16, 2022, sold 197,291 shares in Agilon Health (AGL) for $4,026,709. Following the Form 4...